on GENSIGHT BIOLOGICS S.A. (EPA:SIGHT)
GenSight Biologics Schedules Annual General Meeting for May 2026
GenSight Biologics, a biopharma firm specializing in gene therapies, has set its Annual General Meeting for May 19, 2026. The meeting will occur at 2:00 pm CEST at the company's headquarters in Paris, with an option for shareholders to join through a live webcast.
The agenda and draft resolutions have already been published in the French BALO. A subsequent notice confirming the meeting details will appear in a legal gazette by May 4, 2026. Interested shareholders can access preparatory documents on the company's website or request them via email.
The company emphasizes the availability of these documents in compliance with French legal codes. Shareholders may request additional details by contacting investor relations, provided they validate their shareholder status.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all GENSIGHT BIOLOGICS S.A. news